Direct Observations of Amyloid β Self-Assembly in Live Cells Provide Insights into Differences in the Kinetics of Aβ(1–40) and Aβ(1–42) Aggregation  by Esbjörner, Elin K. et al.
Chemistry & Biology
ArticleDirect Observations of Amyloid b Self-Assembly
in Live Cells Provide Insights into Differences in
the Kinetics of Ab(1–40) and Ab(1–42) Aggregation
Elin K. Esbjo¨rner,1,2,* Fiona Chan,3 Eric Rees,3 Miklos Erdelyi,3 Leila M. Luheshi,1 Carlos W. Bertoncini,4
Clemens F. Kaminski,3 Christopher M. Dobson,1 and Gabriele S. Kaminski Schierle3,*
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
2Department of Chemical and Biological Engineering, Division of Chemistry and Biochemistry, Chalmers University of Technology,
Kemiva¨gen 10, 41296 Gothenburg, Sweden
3Department of Chemical Engineering and Biotechnology, University of Cambridge, New Museums Site, Pembroke Street,
Cambridge CB2 3RA, UK
4Laboratory of Molecular Biophysics, Institute for Research in Biomedicine, Baldiri Reixac 10-12, 08028 Barcelona, Spain
*Correspondence: eline@chalmers.se (E.K.E.), gsk20@cam.ac.uk (G.S.K.S.)
http://dx.doi.org/10.1016/j.chembiol.2014.03.014
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
Insight into how amyloid b (Ab) aggregation occurs
in vivo is vital for understanding the molecular path-
ways that underlie Alzheimer’s disease and requires
new techniques that provide detailed kinetic and
mechanistic information. Using noninvasive fluores-
cence lifetime recordings, we imaged the formation
of Ab(1–40) and Ab(1–42) aggregates in live cells.
For both peptides, the cellular uptake via endocy-
tosis is rapid and spontaneous. They are then re-
tained in lysosomes, where their accumulation leads
to aggregation. The kinetics of Ab(1–42) aggregation
are considerably faster than those of Ab(1–40) and,
unlike those of the latter peptide, show no detectable
lag phase.We used superresolution fluorescence im-
aging to examine the resulting aggregates and could
observe compact amyloid structures, likely because
of spatial confinement within cellular compartments.
Taken together, these findings provide clues as to
how Ab aggregation may occur within neurons.
INTRODUCTION
The misfolding and aberrant self-assembly of specific proteins
into extracellular deposits or intracellular inclusions are the path-
ological characteristics of a range of severe and debilitating
neurodegenerative disorders (Chiti and Dobson, 2006). In partic-
ular, the amyloid b peptide (Ab) has been identified as a central
and causative constituent of the pathology of Alzheimer’s dis-
ease (AD), the most prevalent form of adult dementia (Hardy
and Allsop, 1991). Ab exists in several isoforms of which the
40-residue variant, Ab(1–40), is themost abundant variant in vivo,
whereas the more aggregation-prone, 42-residue variant, Ab(1–
42), is the major proteinaceous component of the extracellular
senile plaques that are the hallmarks of this disease (Glenner
and Wong, 1984; Masters et al., 1985).732 Chemistry & Biology 21, 732–742, June 19, 2014 ª2014 The AutThe phenomenon of Ab fibril formation has been studied
extensively in vitro (Jarrett et al., 1993; Lomakin et al., 1996),
and the recent development of sensitive fluorescence-based
methods has shown that it is also becoming possible to trace
in some detail the population of intermediate states (Lee et al.,
2011; Narayan et al., 2012). Recent progress in the analysis of
the kinetics of fibril formation has, in addition, revealed details
of the microscopic assembly processes that underlie complex
protein aggregation reactions, including those of Ab, allowing
for a mechanistic understanding of protein aggregation behavior
under well defined and carefully controlled conditions in vitro
(Cohen et al., 2013; Cohen et al., 2012). It is, therefore, of consid-
erable interest and importance to find a way to provide detailed
descriptions of the nature of the amyloid species formed during
the aggregation of the Ab peptide in vivo and to monitor directly
in situ the kinetics of Ab assembly. Such information should
enable us to gain mechanistic insights into the processes by
which Ab aggregates are generated and how they proliferate in
their specific biological contexts.
Most observations of Ab aggregates formed in cells or tissue
rely on indirect or invasive techniques, such as the collection
of secreted Ab oligomers in cell culture media (Walsh et al.,
2000), biochemical analysis of high-molecular-weight aggre-
gates in cell lysates (Hu et al., 2009), or immunohistochemical
staining of aggregates in fixed samples (Capetillo-Zarate et al.,
2011; Takahashi et al., 2004). Such approaches have revealed
important results, showing, for example, that Ab aggregates
can, at least under certain circumstances, occur within neurons
aswell as in extracellular deposits. Additional methods are, how-
ever, needed to continuously monitor the kinetics of aggregation
at the level of detail that is required to describe and understand
the mechanistic steps involved in the self-assembly reactions
that result in Ab amyloid formation in vivo.
To address the nature and dynamics of the process of Ab
assembly in neurons, we took advantage of recently developed
procedures that enable the conversion of proteins into amyloid
fibrils to be monitored with great sensitivity by following the
changes in the fluorescence lifetime of covalently linked dye
labels. Such lifetimes have been shown to correlate directly
with the appearance of b sheet-rich amyloid structures (Kaminskihors
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development within a given sample. This approach makes it
possible to use fluorescence lifetime imaging (FLIM) to monitor
amyloid formation and, thus, complements previously devised,
two-color fluorescence resonance energy transfer imaging
methods for in vivo amyloid studies (Klucken et al., 2006; Roberti
et al., 2007). We have used this technique in previous studies to
image in real time, with the optical resolution of a confocal micro-
scope, the formation of amyloid aggregates of a-synuclein and
Tau in vitro from protein in solution and in vivo using a
C. elegans model of Parkinson’s disease (Kaminski Schierle
et al., 2011a; Michel et al., 2014).
In this study we utilized this methodology to study the kinetics
of aggregation of Ab(1–40) and Ab(1–42), the two most common
isoforms of the Ab peptide, during their cellular uptake and sub-
sequent vesicular trafficking within live neuronal cells. A partic-
ular objective has been to gain insights into the phenomenon
of accumulation of intraneuronal Ab species. Intraneuronal Ab
has been observed in the brains of AD patients (Gouras et al.,
2000) as well as in mouse models of AD (Billings et al., 2005)
before the appearance of extracellular plaques. It is possible
that at least some of this intraneuronal Ab has been taken up
from extracellular Ab pools, especially in light of the observation
that fluorescently labeled Ab injected into the tail veins of mice
with a compromised blood-brain barrier accumulates in neurons
in the cerebral cortex (Clifford et al., 2007).
We also used the FLIM methodology in combination with
superresolution imaging techniques (Kaminski Schierle et al.,
2011b; Pinotsi et al., 2014) to relate the observed fluorescence
lifetime to the physical size and shape of the Ab aggregates
in situ. The results show how the uptake of Ab peptides from
the external environment promotes the formation of Ab aggre-
gates within neuronal cells and identifies features in the in vivo
aggregation kinetics of Ab(1–40) and Ab(1–42) that are valuable
in developing an understanding of the mechanistic details of
how intracellular Ab may contribute to AD pathogenesis.
RESULTS
The Dependence of the Fluorescence Lifetime of the
Hilyte Fluor 488 Dye on the Amyloidogenic State of the
Ab Peptide
Fluorescencemicroscopy is a powerful method for the detection
of protein inclusions in cells by using fluorescence intensity as an
indicator of aggregate formation (Kaganovich et al., 2008),
although more advanced readouts are required to obtain infor-
mation on the structural characteristics of the aggregation pro-
cess. Indeed, more information can be obtained by measuring
the fluorescence lifetime because this parameter has been found
to be sensitive to the structural transition from disordered states
into cross-b amyloid fibrils, specifically as a consequence of the
changes in the fluorescence lifetimes as aggregation proceeds
(Chan et al., 2013; Ghukasyan et al., 2010; Kaminski Schierle
et al., 2011a; Michel et al., 2014; Pinotsi et al., 2013).
We first examined whether a Hilyte Fluor 488 (HF488) dye
attached to the N termini of Ab(1–40) and Ab(1–42) could act
as a reporter of amyloid formation bymonitoring how the fluores-
cence intensity of the dye changes as fibril formation occurs
in vitro for each of the two Ab isoforms. The appearance ofChemifibrillar species was identified by means of dot blot experiments
using the conformation-specific antibody LOC (Kayed et al.,
2007), and the HF488 fluorescence intensity was measured in
parallel (Figure 1A; Figure S1 available online). Significant fluo-
rescence quenching was observed to take place on a similar
time scale as that of the appearance of fibrillar species, although
the decrease in fluorescence intensity was somewhat slower
than the increase in LOC immunoreactivity. This small difference,
however, could result from the fact that LOC recognizes fibrillar
oligomers as well as amyloid fibrils, whereas the fluorescence
quenching is likely to be associated predominately with amyloid
fibrils. We also confirmed the formation of b sheet structure by
measurement of circular dichroism spectra at the beginning
and end of the time course of the experiment (Figure 1B). Next,
we used FLIM to analyze these samples collected at the begin-
ning and end of the time course of the experiment. The fluores-
cence lifetimes in each pixel of these images were obtained by
fitting monoexponential decay functions to the observed time-
resolved fluorescence decays, and the data and images are
shown in Figures 1C and 1D. The mean fluorescence lifetime
for solutions containing fibrillar HF488Ab(1–42) (3.3 ± 0.1 ns) was
observed to be substantially lower than those containing mono-
meric HF488Ab(1–42) (3.7 ± 0.05 ns), whereas larger aggregates
of HF488Ab(1–42) (as well as of HF488Ab(1–40)) that were observed
to deposit on the coverslip had even shorter lifetimes, often in the
range of 2.5–3.0 ns. Similar results were obtained for HF488Ab(1–
40) (Figure 2; Figure S2), indicating that there are no inherent
differences between the two Ab isoforms in the context of the
fluorescence lifetime changes exhibited by the HF488 reporter
dye during aggregation. The results show that FLIM readings
enable the detection of aggregated forms of HF488-labeled Ab
peptides and can distinguish these species from the corre-
sponding labeled monomers.
For the HF488 dye to function as a direct reporter of amyloid
formation in vivo, its fluorescence lifetime must respond to the
conformational changes associated with amyloid formation but
remain largely unaffected by extrinsic factors, such as the solu-
tion conditions that the Ab peptides may encounter in the living
cell. Therefore, we examined the response of the HF488 dye it-
self to a change in pH from 7.4 to 5.0 and found that the dye
has a lifetime of 4.0 ± 0.1 ns in both cases (Figure 1E). That is,
it is insensitive to pH changes in this range. We also found that
its fluorescence lifetime is constant, within experimental error,
across a wide range of dye concentrations (Figure S1B). This
result shows that the intracellular accumulation of Ab peptides
would not, in the absence of aggregation, result in a reduction
of fluorescence lifetime as a consequence of self-quenching
interactions. Furthermore, the fluorescence lifetime of the un-
conjugated HF488 dye (4.0 ± 0.1 ns) is longer than that of the
Ab-conjugated dye (3.7 ± 0.05 ns), perhaps as a result of interac-
tions between the dye and the polypeptide chain in the latter
case (Chen et al., 2010). This finding suggests, therefore, that it
may be possible to restore the fluorescence lifetime of HF488
by proteolytic degradation of the Ab peptide. We tested this
idea by treating HF488Ab(1–40) with trypsin, a procedure that re-
sults in the cleavage of the Ab peptide into short fragments. This
treatment resulted in an increase in the mean fluorescence life-
time from 3.7 ± 0.1 ns to 4.0 ± 0.1 ns (Figure 1E), indicating
that, unless the fluorescence lifetime of Ab is observed tostry & Biology 21, 732–742, June 19, 2014 ª2014 The Authors 733
Figure 1. Amyloid Fibril Formation and Fluorescence Lifetimes of the HF488-Labeled Ab Peptides In Vitro
(A) Amyloid formation by HF488Ab(1–42) (5 mM in 50 mM sodium phosphate buffer [pH 7.4]) as a function of time. The quantity of amyloid fibrils was monitored by
immunochemistry using the conformation-specific antibody LOC (red circles and dashed line) to detect fibrillar species. The normalized fibril quantity (relative to
the maximum value) is given on the right axis in the graph. The amyloid formation was also monitored by the decrease in fluorescence emission intensity of the
HF488 dye (blue). a.u., arbitrary units. See also Figure S1A.
(B) Far UV circular dichroism spectra of monomeric and fibrillar Ab(1–42).
(C) Fluorescence lifetime images of solutions of monomeric and fibrillar HF488Ab(1–42). The lifetime color coding is shown in the bar to the right of the images. The
frequency histograms show the per-pixel distribution of HF488 fluorescence lifetimes in each of the images.
(D) Mean fluorescence lifetime (± SD) of the unconjugated HF488 dye at different pH values and for monomeric, fibrillar, and trypsin-treated monomeric
HF488Ab(1–40).
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intact peptide chain. Taken together, therefore, these data sug-
gest that the fluorescence lifetime of the HF488 dye constitutes a
robust and specific reporter of the formation of amyloid fibrils by
the Ab peptides.
To further test the potential of the HF488 dye to report on the
aggregation behavior of Ab and the extent of amyloid formation,
we examined the degree to which the changes in the mean fluo-
rescence lifetime reflect the kinetics of amyloid formation in a
sample of HF488Ab(1–40) mounted on the stage of the FLIM
microscope (Figure 2). The decrease in fluorescence lifetime is
sigmoidal and proceeded by a lag phase of approximately
2.5 hr (Figure S2A). The observed kinetics are in good agreement
with the appearance of LOC immunoreactive species (Fig-
ure S2B), although the change in fluorescence lifetime is slower734 Chemistry & Biology 21, 732–742, June 19, 2014 ª2014 The Autthan the increase in LOC species, a result consistent with the
data presented in Figure 1. In addition, the fluorescence lifetime
distribution broadens as the aggregation progresses, consistent
with the appearance of an increasingly heterogeneous popula-
tion of HF488Ab(1–40) aggregates.
Uptake and Intracellular Localization of HF488Ab(1–40)
and HF488Ab(1–42)
Ab peptides have been reported to be internalized into a variety
of cell types, including neurons (Burdick et al., 1997; Friedrich
et al., 2010; Hu et al., 2009; Kaminski Schierle et al., 2011b;
McGuire et al., 2012). To characterize the uptake and intracel-
lular localization of the peptides under the conditions used
in our study, we added aliquots of monomeric HF488Ab(1–40)
or HF488Ab(1–42) to cultures of SH-SY5Y human neuroblastomahors
Figure 2. Kinetics of HF488Ab(1–40) Fibril
Formation Monitored by Fluorescence Life-
time Imaging
Fluorescence lifetime images and corresponding
frequency histograms showing the evolution of
the HF488 fluorescence lifetime in a defined vol-
ume of a droplet sample of HF488Ab(1–40) depos-
ited onto a glass-bottomed culture dish and
mounted on the FLIM microscope. The color
coding of images and histograms relate to the
color bar on the right. The HF488Ab(1–40) concen-
tration was 5 mM, and the peptide was diluted into
50mMsodium phosphate buffer (pH 7.4). See also
Figure S2.
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cellular medium. Intracellular green HF488 fluorescence, which
was colocalized with the red fluorescence from the membrane-
impermeable endocytosis marker FM 4–64, was observed
readily after 30 min of exposure to the labeled peptides (Figures
3A and 3C).; Moreover, lower levels of intracellular HF488
fluorescence could be detected after 10 min (Figure S3), indi-
cating rapid internalization of the peptides. The absence of
enhanced HF488 fluorescence (green) in the plasma membrane
(brightly stained in red by the hydrophobic FM 4–64 dye)
compared with the fluorescence intensity in the surrounding
extracellular medium suggests that neither HF488Ab(1–40) nor
HF488Ab(1–42) accumulates significantly at the plasma mem-
brane prior to internalization. Images acquired after 24 hr
show that both HF488Ab(1–40) and HF488Ab(1–42) appear as
granular intracellular deposits and that the peptides colocalize
with LysoTracker red, confirming their compartmentalizationChemistry & Biology 21, 732–7within acidic organelles (Figures 3B and
3C). The neuronal cells were also
incubated for 1 hr at 37C and at
4C to compare uptake under condi-
tions that, respectively, permit or inhibit
endocytosis. The cells did not inter-
nalize any detectible quantities of either
HF488Ab(1–40) or HF488Ab(1–42) at 4C,
suggesting that uptake of the mono-
meric Ab peptides occurs via an active
uptake pathway (Figure 3E).
Intracellular Aggregation of
Ab(1–40) andAb(1–42)Monitored by
Live Cell Fluorescence Lifetime
Imaging
Having established that the fluorescence
lifetime of HF488 acts as a reporter of
amyloid formation of Ab(1–40) and
Ab(1–42), we set out to investigate how
the aggregation state of each of the
two peptide isoforms is affected by its
cellular uptake and accumulation in
acidic organelles in SH-SY5Y cells. Using
FLIM, we observed that there are no sig-
nificant differences (p = 0.95, Table S1)
in the fluorescence lifetimes of extracel-lular and internalized HF488Ab(1–40) during the first 6 hr after
application of 500 nM peptide to the culture medium (Figures
4A and 4D), indicating the presence of similar HF488Ab(1–40)
species within the cells as those applied to the extracellular
environment. The fluorescence intensity images, however,
show that the developing intracellular fluorescence becomes
significantly brighter than the extracellular fluorescence, which
clearly indicates that the HF488Ab(1–40) peptide molecules
have accumulated within the cells over this time period. We
then examined the cells treated with the same concentration
of HF488Ab(1–40) for 24 and 48 hr (Figures 4C and 4D), washing
them prior to imaging to remove any extracellular fluorescence.
The bar diagram in Figure 4D shows that the fluorescence life-
time of the intracellular peptide decreases over this time interval.
The difference compared with the extracellular starting value,
however, is statistically significant first after 48 hr (p = 0.0032,
Table S1).42, June 19, 2014 ª2014 The Authors 735
Figure 3. Confocal Fluorescence Micro-
scopy Images Showing the Uptake and
Intracellular Localization of HF488Ab(1–40)
and HF488Ab(1–42) in SH-SY5Y Cells
(A and C) Uptake of (A) HF488Ab(1–40) and (C)
HF488Ab(1–42) (green) and the endocytosis marker
FM 4–64 (red) after 30 min of incubation. The white
arrows in the overlay panels indicate colocalization
in intracellular vesicles. Note that the peptides do
not accumulate at the plasma membrane.
(B and D) Colocalization of (B) HF488Ab(1–40) and
(D) HF488Ab(1–42) (green) with LysoTracker red
(red) after 24 hr of incubation with 500 nM peptide
followed by 1 hr of incubation with 100 nM
LysoTracker red.
(E) Uptake of HF488Ab(1–40) and HF488Ab(1–42)
upon incubation at 37C (allowing endocytotic
internalization) and 4C (inhibiting endocytotic
internalization). The images show the overlay of
HF488 fluorescence (green) and the transmitted
image. All scale bars represent 10 mm. See also
Figure S3.
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we observed a trend of a progressive intracellular fluorescence
lifetime decrease with time (Figures 4B and 4D). Indeed, the dif-
ference compared with the extracellular fluorescence lifetime at
time 0 is statistically significant at the 6-hr time point (p = 0.0028,
Table S1), and, after 24 hr, the lifetime has reached its lowest
value (Figure 4C). There is, therefore, a clear difference between
the two peptides with respect to the kinetics by which intracel-
lular species with reduced fluorescence lifetimes are formed.
HF488Ab(1–42) displays a faster fluorescence lifetime decay
than HF488Ab(1–40), although both reach endpoint values
(3.35 ± 0.2 ns for HF488Ab(1–40) compared with 3.31 ± 0.2 ns
for HF488Ab(1–40) that are statistically indistinguishable (p =
0.22, Table S2). In addition, HF488Ab(1–40) appears to exhibit a
lag phase in its aggregation, whereas HF488Ab(1–42) shows no
such effect and aggregates rapidly soon after it is internalized
into the cells (Figure 4D).736 Chemistry & Biology 21, 732–742, June 19, 2014 ª2014 The AuthorsDirect Stochastic Optical
Reconstruction Microscopy of
HF647Ab(1–40) and HF647Ab(1–42) in
Cells
To further investigate the nature of the
intracellular Ab(1–40) and Ab(1–42) ag-
gregates, we used superresolution fluo-
rescence microscopy to analyze their
physical appearance. We have demon-
strated recently that it is possible to
obtain single-molecule localization of
Hilyte Fluor 647 fluorophores attached
to preassembled or spontaneously
formed amyloid fibrils in fixed cells
using direct stochastic optical recon-
struction microscopy (dSTORM) (Kamin-
ski Schierle et al., 2011b). Thus, we
treated SH-SY5Y cells with 500 nM of
HF647Ab(1–40) or 500 nM of HF647Ab(1–
42) monomers for periods of 24 and48 h. Thereafter, the cells were fixed, immersed in switching
buffer, and imaged at single-molecule resolution using a home-
built total internal reflection fluorescence (TIRF) microscope
operated under highly inclined illumination (Tokunaga et al.,
2008) to obtain images from an image plane within the
cells. Superresolved images (Figure 5A) of the intracellular
HF647Ab(1–40) and HF647Ab(1–42) aggregates were then recon-
structed as described in the Experimental Procedures. dSTORM
results in a dramatic increase in resolution compared with con-
ventional confocal imaging (Figure S4). In this case, the lateral
resolution of our images was calculated to be 55–70 nm using
a blind assessment density estimation approach (Rees et al.,
2012). Features larger than the lateral resolution limit can,
therefore, be interpreted with confidence as having approxi-
mately the correct size and shape. The images taken after
24 hr (Figure 5A) show that the intracellular HF647Ab(1–40) aggre-
gates are mainly spherical, and we estimated their average
Figure 4. Fluorescence Lifetime Imaging of the Uptake and Accumulation of HF488Ab(1–40) and HF488Ab(1–42) in Live SH-SY5Y Cells
(A andB) Cells treatedwith (A) 500 nM HF488Ab(1–40) or (B) 500 nM HF488Ab(1–42) for 0–6 hr. The upper panels show fluorescence intensity, the center panels show
HF488 fluorescence lifetimes, and the lower panels show the normalized per-pixel HF488 fluorescence lifetime frequency (Norm. Freq.) in the corresponding
image above. The histograms at the 0 hr time point show the HF488 fluorescence lifetime distribution of the extracellular peptides (E.C.). Subsequent histograms
(1, 3, and 6 h) show the HF488 fluorescence lifetime distributions of the intracellular peptides only. See the color bar in (C) for the color coding of FLIM images and
frequency histograms.
(C) Cells treated with 500 nM HF488Ab(1–40) or 500 nM HF488Ab(1–42) for 24 or 48 hr. The cells were washed once prior to imaging. The images show an overlay of
the color-coded FLIM image and the transmitted image. The HF488 fluorescence lifetime frequency histograms show the distribution over several analyzed
images (n = 6–9). Trans., transmission.
(D) Mean HF488 fluorescence lifetime (± SEM) of extracellular and intracellular HF488Ab(1–40) and HF488Ab(1–42). At 0 hr, the bars represent the mean HF488
fluorescence lifetime (± SEM) of the extracellular peptide (E.C.). The subsequent bars show the mean HF488 fluorescence lifetime (± SEM) of the intracellular
peptides at the indicated time points after addition of 500 nM HF488Ab(1–40) or 500 nM HF488Ab(1–42) to the culture medium. Asterisks (*) over bars indicate a
significant difference compared to 0 h (E.C.), and lines over bars indicate a significant difference between the two peptides at the specified time points according
to Fisher’s least significant difference test (p < 0.05). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Individual p values are given in Tables S1 and S2.
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counting. The HF647Ab(1–42) aggregates, by contrast, appear
to include both spherical and elongated species, with an average
size along their longest dimension of approximately 225 nm
(Figure 5B). The observation that, after 24 hr, HF647Ab(1–42)
forms intracellular species that are larger than those formed by
HF647Ab(1–40) is consistent with the differences in their mean
fluorescence lifetimes (Figures 4C, 4D, and 5C). Together, theseChemiobservations suggest a higher degree of conversion into amyloid
fibrils after 24 hr for HF647Ab(1–42) in relation to HF647Ab(1–40).
After 48 hr, the HF647Ab(1–40) aggregates remain predominantly
spherical, but they appear to have increased in size (Figure 5B),
suggesting a continued recruitment of monomers into the amy-
loid aggregates, which is consistent with the fluorescence life-
time change observed for HF488Ab(1–40) between 24 and 48 hr
(Figures 4C, 4D, and 5C). There is no significant change in thestry & Biology 21, 732–742, June 19, 2014 ª2014 The Authors 737
Figure 5. Super-Resolution Fluorescence Microscopy Imaging of Intracellular Ab(1–40) and Ab(1–42)
(A) dSTORM images of intracellular HF647Ab(1–40) and HF647Ab(1–42) in fixed SH-SY5Y cells. The cells were imaged after 24 and 48 hr of incubation. Scale bars
represent 1 mm.
(B) Mean size of the intracellular aggregates (± SEM) estimated by pixel counting in dSTORM images. The lines above the bars indicate statistically significant
mean differences (paired Student’s t test; *p < 0.05; n = 18–27). Only aggregates with dimensions exceeding the resolution limit were included in the analysis.
(C) Mean fluorescence lifetime (± SEM) of intracellular HF488Ab(1–40) and HF488Ab(1–42) at the time points corresponding to the dSTORM images. The data were
extracted from Figure 4D.
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indicating a correlation consistent with the FLIM results. Com-
parison of the FLIM and dSTORM data recorded after 24 and
48 hr indicates a qualitative relationship between aggregate
size and HF488 fluorescence lifetime (Figures 5B and 5C), sup-
porting the conclusion that the fluorescence lifetime reflects
the nature and abundance of the Ab amyloid aggregates formed
in vivo.
DISCUSSION
The misfolding and formation of amyloid aggregates by Ab pep-
tides, particularly Ab(1–42), is now well established as a central
and causative step in the onset and progression of the molecular
transformations leading to neurodegeneration and, ultimately, to
the development of AD. The ability to directly monitor by exper-
iment the dynamics of the aggregation process in live specimens
is, therefore, a crucial step in defining the nature of the molecular
events that initiate the assembly and proliferation of Ab aggre-
gates in vivo. We describe here a combination of fluorescence-
based microscopy techniques designed to overcome the
challenging nature of such experiments that have enabled us
to study, in real time, the dynamics by which fluorescently
labeled Ab peptides form aggregates within acidic organelles
of the endocytotic pathway of live neurons and to characterize
their amyloidogenic nature and size.
In this study, we confirm results from others indicating that
both Ab(1–40) and Ab(1–42) are taken up and then accumulate
in human neuronal cells (Hu et al., 2009). We show, in addition,
that this uptake is rapid and spontaneous, that it occurs without738 Chemistry & Biology 21, 732–742, June 19, 2014 ª2014 The Autany apparent accumulation of peptide molecules in the plasma
membrane, that it is temperature-dependent, and that the inter-
nalized peptide molecules colocalize with markers for endocy-
tosis and acidic vesicular organelles. Taken together, these
observations indicate that monomeric Ab(1–40) and Ab(1–42)
are both taken up into the cells as monomers and via active
endocytotic pathways, although it has been shown that other
amyloid species, including oligomers (Campioni et al., 2010)
and fibrils (Kaminski Schierle et al., 2011b; McGuire et al.,
2012), if present in the cellular medium, can also be taken up
via nonendocytotic pathways. We observe retention of Ab in
acidic compartments over 48 hr, suggesting their localization
in lysosomes in accord with the findings of several previous
studies (Burdick et al., 1997; Hu et al., 2009; Knauer et al.,
1992). By monitoring the changes in fluorescence lifetimes of
internalized HF488Ab(1–40) and HF488Ab(1–42), we have been
able to show that the accumulation of monomeric species into
acidic organelles results in the gradual formation of Ab aggre-
gates, as demonstrated by the decrease in fluorescence lifetime
of intracellular Ab as a function of time.
Despite the apparent similarities in observed endocytotic
uptake and intracellular accumulation of HF488Ab(1–40) and
HF488Ab(1–42), our findings reveal substantial differences in the
kinetic rate profiles by which the two Ab isoforms form intracel-
lular aggregates within the vesicular compartments of the cell.
In short, intraneuronal HF488Ab(1–40) does not exhibit detectable
changes in its fluorescence lifetime during the first 6 hr of incuba-
tion, although a decrease in fluorescence lifetime is evident after
48 hr. This rate profile indicates the existence of a significant
lag phase for intracellular Ab(1–40) aggregation. By contrast,hors
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mean fluorescence lifetime, despite showing a distinctive,
although short, lag phase in vitro (Figure 1), in agreement with
previous studies (Cohen et al., 2013). Thus, although the overall
slower aggregation kinetics of intracellular HF488Ab(1–40) relative
to intracellular HF488Ab(1–42) are consistent with their intrinsic
aggregation propensities (Jarrett et al., 1993), our results reveal
an important difference in the details of their aggregation reac-
tions in vivo, where, in particular, HF488Ab(1–42) appears to pro-
ceed to form amyloid fibrils without a lag phase.
The absence of a detectable lag phase in the case of
HF488Ab(1–42) cannot be interpreted definitely from this experi-
ment, although it is likely to be associated with the fact that the
aggregation proceeds in lysosomes, where the environment is
relatively acidic. This pH change brings the peptide closer to
its isoelectric point, and several in vitro studies indeed suggest
that this results in strongly accelerated Ab amyloid formation
(Burdick et al., 1992; Su and Chang, 2001; Wood et al.,
1996). A more detailed interpretation of the rate profiles would
require detailed knowledge of the intracellular concentration
and of the mechanism of nucleation that exist in the cellular
environments (Cohen et al., 2013; Cohen et al., 2012). Never-
theless, our findings are consistent with the observation that
neurons in regions of the brain that are most vulnerable in AD
accumulate Ab(1–42) preferentially relative to Ab(1–40),
although the latter peptide isoform is more abundant (Gouras
et al., 2000). The demonstration of the rapid formation of
Ab(1–42) aggregates in vivo is also particularly interesting in
light of a recent in vitro study that has revealed that the pres-
ence of such aggregates can result in the rapid generation of
toxic oligomeric species through catalytic secondary nucleation
(Cohen et al., 2013).
In addition to studying the kinetics of amyloid formation by
FLIM in vivo, we also used superresolution fluorescence imag-
ing to examine the size and shape of the resulting Ab aggregates
in situ. We can conclude that the uptake of monomeric Ab and
its subsequent amyloid formation result in the formation of rela-
tively small and compact amyloid structures. Their physical size
is of the order of 150–300 nm along their longest dimension (Fig-
ure 5B), and their macroscopic structures are, in most cases,
too dense to discern individual fibrils (although we can observe
some higher aspect ratio structures for HF647Ab(1–42)). These
observations contrast with the extended shape of well sepa-
rated fibrils formed by these Hilyte-labeled peptides in vitro
(Narayan et al., 2012) and suggests that spatial confinement
within cellular compartments has a large influence on the
macroscopic structure of the assembled fibrils. In this context,
however, it is interesting to compare these findings to our pre-
vious dSTORM studies of intracellular Ab, in which we incubated
HeLa cells with a mixture of monomers and short, preformed
fibrils (Kaminski Schierle et al., 2011b) and, thereafter, observed
rapid fibril growth and clearly discernable individual fibrils within
cells.
Finally, we note a qualitative correlation between the average
sizes of intracellular HF647Ab aggregates and the mean fluores-
cence lifetimes of the corresponding HF488Ab aggregates. This
observation supports the view that fluorescence lifetime is a
sensitive measure of the extent of amyloid formation both
in vitro and in vivo.ChemiSIGNIFICANCE
We demonstrated that it is possible to measure, noninva-
sively, the kinetics of the process by which fluorescently
labeled Ab(1–40) and Ab(1–42) peptides form amyloid aggre-
gates in acidic vesicular compartments within live neurons
following the endocytotic uptake of Ab monomers from the
extracellular medium. By this approach, we identified differ-
ences in the self-assembly of intraneuronal Ab(1–40) and
Ab(1–42), with the latter aggregating more rapidly than the
former and without any detectable lag phase. We also
imaged the macroscopic structure of the ensuing Ab aggre-
gates in situ and showed that their physical size correlates
qualitatively with the extent towhich each peptide has adop-
ted an amyloid structure. This work demonstrates that it is
possible to resolve the structural dynamics of the assembly
of Ab aggregates in vivo, andwe envisage that this approach
will significantly enhance our ability to define and under-
stand the mechanisms through which this key event in the
development of AD can occur. We envisage that the latter
will increase the likelihood of finding strategies to design
rational approaches for therapeutic interventions directed
at combatting the onset and progression of neurodegenera-
tive conditions.
EXPERIMENTAL PROCEDURES
Reagents
Synthetic Ab(1–40) and Ab(1–42) peptides, labeled at the N terminus with
HF488 or HF647 and Hilyte Fluor 488 acid (free dye) were purchased from
Anaspec. The fibril-specific LOC antibody (rabbit polyclonal, catalog no.
AB2287) was obtained from Millipore, and the secondary Alexa Fluor 647-
labeled anti-rabbit antibody was obtained from Life Technologies. The human
neuroblastoma SH-SY5Y cells were from Sigma.
Preparation and Handling of the Ab Peptides
The lyophilized peptides were dissolved in 1% ammonium hydroxide (v/v) at
4C. The solutions were then vortexed briefly and divided into aliquots that
were immediately frozen and stored below 20C until further use to avoid
any aggregation. The concentration of the peptides in the aliquots was
determined by absorption spectroscopy using an extinction coefficient of
70,000 M1cm1 at 503 nm for the HF488 dye and an extinction coefficient
of 250,000 M1cm1 at 649 nm for the HF647 dye. A fresh aliquot was used
for each experiment to avoid repeated freeze-thaw cycles that could trigger
potential aggregate formation.
Ab Peptide Aggregation in Vitro
All in vitro experiments were performed at a peptide concentration of 5 mM in
50 mM sodium phosphate buffer at pH 7.4. Aggregation kinetics were moni-
tored by steady-state fluorescence in a FLUOstar Optima microplate reader
(BMG Labtech) and sealed black Costar half-area, 96-well plates (Corning
Life Sciences). Data were recorded at 5-min intervals using a 480-nm band-
pass filter for excitation and a 520-nm bandpass filter for emission. Orbital
shaking (300 rpm, 10 s) was carried out prior to each recording to ensure
that each sample was homogenous. Sample aliquots for dot blot analysis
were taken at the indicated time points and immediately flash-frozen in liquid
nitrogen. These aliquots were thawed by dilution into phosphate buffer to a
total volume of 25 ml and immediately blotted onto a nitrocellulose membrane
using a Bio-Rad dot blot apparatus. Themembrane was blockedwith 5% (w/v)
dry milk and 0.1% Triton X-100 in PBS and stained with LOC as the primary
antibody and an Alexa Fluor 647-labeled anti-rabbit antibody as the secondary
antibody (Life Technologies). The blots were imaged on a Typhoon 9400 scan-
ner (GE Healthcare) using the 633-nm laser line for excitation. Densitometric
analysis of the blots was carried out using ImageJ. (Schneider et al., 2012).stry & Biology 21, 732–742, June 19, 2014 ª2014 The Authors 739
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bottomed tissue culture dish (MatTek) and sealed with a coverslip and nail var-
nish to avoid evaporation.
Optical Spectroscopy
Absorption spectra were recorded on a Cary 400 UV-Vis spectrophotometer
(Agilent). Circular dichroism spectra were recorded on a J-810 spectropo-
larimeter (JASCO) between 190–250 nm in 1-nm wavelength increments
with a scan speed of 50 nm/min, a response time of 0.5 s, and a bandwidth
of 2 nm. Twenty scans were accumulated and averaged. Spectra were
corrected for background contributions by subtracting the appropriate
blanks.
Cell Culture and Sample Preparation
Human neuroblastoma cells (SH-SY5Y) were grown in 1:1 minimal essential
medium (MEM) and nutrient mixture F-12 Ham (Sigma-Aldrich) with sodium
bicarbonate, including 15% heat-inactivated fetal bovine serum, 1% MEM
non-essential amino acids, 2 mM N-glutamine, 1% penicillin-streptomycin
(10,000 U/ml K1), and 0.1% fungizone (amphotericin B, 250 mg/ml K1) (Life
Technologies). Cells were plated 1 day prior to experiments in glass-bottomed
culture dishes (MatTek) at a density of 50,000 cells/14-mm dish. All samples
were washed once in CO2-independent, serum- and phenol red-free medium
(prepared as above but with exclusion of serum and addition of 30 mMHEPES
and B12 supplement [Gibco]). All experiments with cells were performed in at
least duplicates and repeated at least three times. The Ab concentration was
500 nM in all experiments.
Confocal Microscopy
All uptake and colocalization experiments were carried out with the HF488-
labeled Ab peptides using a Leica SP5 confocal microscope (Leica Microsys-
tems). For colocalization with FM 4–64 (Life Technologies), 5 mg/ml of the dye
was added together with the peptide, and images were recorded after 1 hr of
incubation. Both dyes were excited by the 488-nm laser line. HF488 emission
was collected from 520–580 nm and FM 4–64 emission between 700–800 nm.
For colocalization with LysoTracker red (Life Technologies), cells were incu-
bated with HF488-labeled peptide for 24 hr, washed once with serum-free
medium, and thereafter incubated for 1 hr with 100 nM LysoTracker red before
images were recorded. LysoTracker red was excited using the 647-nm laser
line, and emission was collected between 700–800 nm. Sequential acquisition
was used in all experiment to avoid bleed-through and cross-excitation.
Cellular uptake at 4Cwas assessed by keeping the cells in a cold room during
incubation. The cells were washed prior to imaging to avoid uptake while
observing the cells on the microscope.
FLIM
All FLIM experiments were carried out using HF488-labeled Ab peptides, and
images were recorded by time-correlated single photon counting (TCSPC)
using a confocal microscopy platform built on an Olympus Fluoview FV300
confocal scan unit. A pulsed supercontinuum source (SC 450, Fianium) was
used for excitation, emitting a train of sub-10-picosecond pulses at 40 MHz
repetition rate. The output beam was collimated and passed through a hot
mirror assembly to remove infrared components at wavelengths greater than
700 nm. The visible portion of the spectrum was passed through an
acousto-optic tunable filter (AOTFnC-VIS, AA Opto-Electronic) whose radio
frequency modulator was driven by software developed using LabVIEW
(National Instruments). The excitation wavelength was set to 480 nm. The exci-
tation beam was reflected onto the sample with a 20/80 broad bandwidth
coated beam splitter so that 20% of the excitation light passed on to the sam-
ple and 80% of the fluorescence signal was reflected toward the confocal
pinhole. The fluorescence light was passed through a 515-nm Semrock
long-pass filter (Laser 2000) and passed onto a fast photomultiplier tube
(PMC-100, Becker & Hickl). Lifetimes were recorded using TCSPC circuitry
(SPC-830, Becker & Hickl). Photon count rates were kept below 1% of the
laser repetition rate to prevent pulse pileup. Images were acquired in 10 cycles
of 10–30 s. All TCSPC images were processed initially using SPCImage soft-
ware (Becker & Hickl) and fitted as monoexponential decays, taking into
account the instrument response. The instrument response was measured
using reflected light from either a coverslip or a coated mirror. Pixel binning740 Chemistry & Biology 21, 732–742, June 19, 2014 ª2014 The Autwas increased until approximately 3500–5000 photons/pixel were obtained
(corresponding to a binning factor of 2 or 3). Further image analysis was carried
out using Matlab (The Mathworks) and Origin 8.1 (OriginLab) software. Statis-
tical analysis was performed in Origin 8.1 (OriginLab) or GraphPad Prism
(GraphPad Software). The average lifetimes in several independent images
were computed, and these were then averaged to obtain the mean lifetime
(± SEM) for each particular time point and peptide treatment. Significant differ-
ences between treatments were obtained by means of comparison using
paired Student’s t test or Fisher’s least significant difference test (in case of
multiple comparisons). The p values for all individual comparisons are given
in Tables S1 and S2.
dSTORM
All dSTORM experiments were carried out using HF647-labeled peptides.
Fluorescence images for dSTORM were taken on a Nikon Te-300 Eclipse in-
verted wide field microscope, with a 1003, 1.49 numerical aperture TIRF
objective lens, an Andor iXon 887DV electron-multiplying charge-coupled
device camera, and a Semrock fluorescence filter set (LF405/488/561/635-
A-00). To induce photoswitching, the specimens were immersed in a
‘‘switching buffer’’ solution: 100 mM mercaptoethylamine in PBS (pH 7.4)
together with a glucose enzyme oxygen scavenger (40 mg/ml glucose,
50 mg/ml glucose oxidase, and 1 mg/ml catalase) to slow down photobleach-
ing of the fluorophore. Samples were imaged using highly inclined illumina-
tion from a 642-nm Toptica diode laser at an intensity of 2 kW/cm2 on
the specimen. Stacks of 10,000 images with 25 ms exposure times were
collected.
Superresolution images were reconstructed by applying a ‘‘segmentation
and sparse Gaussian fitting’’ algorithm implemented in Matlab using a
method described previously (Wolter et al., 2010). Briefly, for each frame
of image data, local maxima brighter than a threshold value were fitted to
a Gaussian point spread function to obtain the center position corresponding
to a fluorophore location. Localized fluorophore density was visualized by
assigning each localization onto a superresolution grid of pixels to produce
a fluorophore density histogram as the superresolution image. The number
of photons associated with each localization and the background noise of
the images were also estimated so that the average localization precision
could be evaluated according to Thompson et al. (Thompson et al., 2002)
and used to determine the image resolution (Rees et al., 2012). The sizes
of intracellular Ab aggregates were estimated from the dSTORM images by
counting pixels along their longest dimension. Only aggregates with dimen-
sions exceeding the resolution limit of the experiment were included in the
analysis.
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